Aharon Schwartz is of Protalix BioTherapeutics, Inc.. Currently has a direct ownership of 303,000 shares of PLX, which is worth approximately $496,919. The most recent transaction as insider was on Jun 10, 2025, when has been sold 129,000 shares (Common Stock) at a price of $1.6 per share, resulting in proceeds of $206,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 303K
74.14% 3M change
74.14% 12M change
Total Value Held $496,919

Aharon Schwartz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Open market or private purchase
$206,400 $1.6 p/Share
129,000 Added 29.86%
303,000 Common Stock
Jan 03 2023
BUY
Open market or private purchase
$156,200 $1.42 p/Share
110,000 Added 38.73%
174,000 Common Stock
AS

Aharon Schwartz

Carmiel, L3

Track Institutional and Insider Activities on PLX

Follow Protalix BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLX shares.

Notify only if

Insider Trading

Get notified when an Protalix Bio Therapeutics, Inc. insider buys or sells PLX shares.

Notify only if

News

Receive news related to Protalix BioTherapeutics, Inc.

Track Activities on PLX